Patent issues delaying Ebola cure
Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine
Sub-standard drugs bigger problem than counterfeit drugs: health activists
Problem of poor quality drugs cannot be solved with technology alone, they say
What Durban did not discuss
IPRs are blocking access to mitigation and adaptation technologies. India offers a way out
New endosulfan ploy
Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
WTO gives India a clean chit
Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review
A people’s festival to protest CBD conference
Non-profits to represent united resolve to protect the country’s natural wealth and bio-cultural heritage from powerful economic interests
Environment ministry rapped
Parliament committee says serious inadequacies in afforestation, biodiversity programmes
Biotech industry has a new patron
Department of Biotechnology is playing venture capitalist to private companies to push biotech research in agriculture
Unholy smoke!
Inclusion of intellectual property in bilateral investment agreements is injurious to the health of developing nations
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
EU threat to farmers
Free trade pact with EU will have a severe impact on Indian agriculture, specially the dairy sector
Fall of a premier institute
Amid funds siphoning allegations, future of National Institute of Pharma Education seems bleak
Trade barred
Countries protect their renewable energy equipment. Exporting nations see it as trade barrier
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company
Wooing the judges, openly
There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators
US pharma strikes back
Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …
US piles on the pressure
Patent law, domestic content rules in solar and ICT policy come under attack
Big step for biocultural rights
The Nagoya Protocol promotes community stewardship of genetic resources. India needs to foster this
Coffins for the EU Delegation in Delhi
Health activists protest against the EU-India investment treaty under negotiation now
A treaty too many
India is learning that there is a heavy price to be paid for the large number of bilateral investment treaties, or BITs, it has signed in the …
Future compromised
The Earth Summit was a historical opportunity to set the world on the correct development trajectory. Negotiators from 191 countries came …
The hunt for benefits
India is hailed as a pioneer in implementing the third objective of the Convention on Biological Diversity—fair and equitable sharing of …